Validation of the ‘Suicidality: Treatment Occurring in Paediatrics (STOP) Suite of Measures’ in Clinical and Non-clinical Child and Adolescent Populations | C4C

The objective of this analysis is to identify patients aged between 8 and 18 years who have been recently started (i.e., within two week period) on: 1) fluoxetine or any psychological treatment (e.g., CBT) for Depression; 2) Risperidone or Aripiprazole for any diagnosis. We will use this information to contact participants at 8 time points (4 face-to-face and 4 phone calls) for a 12-month prospective study monitoring medication side-effects, including suicidality